期刊文献+

Mineralocorticoid receptor: a critical player in vascular remodeling 被引量:3

Mineralocorticoid receptor: a critical player in vascular remodeling
原文传递
导出
摘要 Vascular remodeling is a pathological condition with structural changes of blood vessels.Both inside-out and outside-in hypothesis have been put forward to describe mechanisms of vascular remodeling.An integrated model of these two hypotheses emphasizes the importance of immune cells such as monocytes/macrophages,T cells,and dendritic cells.These immune cells are at the center stage to orchestrate cellular proliferation,migration,and interactions of themselves and other vascular cells including endothelial cells(ECs),vascular smooth muscle cells(VSMCs),and fibroblasts.These changes on vascular wall lead to inflammation and oxidative stress that are largely responsible for vascular remodeling.Mineralocorticoid receptor(MR)is a classic nuclear receptor.MR agonist promotes inflammation and oxidative stress and therefore exacerbates vascular remodeling.Conversely,MR antagonists have the opposite effects.MR has direct roles on vascular cells through non-genomic or genomic actions to modulate inflammation and oxidative stress.Recent studies using genetic mouse models have revealed that MR in myeloid cells,VSMCs and ECs all contribute to vascular remodeling.In conclusion,data in the past years have demonstrated that MR is a critical control point in modulating vascular remodeling.Studies will continue to provide evidence with more detailed mechanisms to support this notion. Vascular remodeling is a pathological condition with structural changes of blood vessels.Both inside-out and outside-in hypothesis have been put forward to describe mechanisms of vascular remodeling.An integrated model of these two hypotheses emphasizes the importance of immune cells such as monocytes/macrophages,T cells,and dendritic cells.These immune cells are at the center stage to orchestrate cellular proliferation,migration,and interactions of themselves and other vascular cells including endothelial cells(ECs),vascular smooth muscle cells(VSMCs),and fibroblasts.These changes on vascular wall lead to inflammation and oxidative stress that are largely responsible for vascular remodeling.Mineralocorticoid receptor(MR)is a classic nuclear receptor.MR agonist promotes inflammation and oxidative stress and therefore exacerbates vascular remodeling.Conversely,MR antagonists have the opposite effects.MR has direct roles on vascular cells through non-genomic or genomic actions to modulate inflammation and oxidative stress.Recent studies using genetic mouse models have revealed that MR in myeloid cells,VSMCs and ECs all contribute to vascular remodeling.In conclusion,data in the past years have demonstrated that MR is a critical control point in modulating vascular remodeling.Studies will continue to provide evidence with more detailed mechanisms to support this notion.
出处 《Science China(Life Sciences)》 SCIE CAS 2014年第8期809-817,共9页 中国科学(生命科学英文版)
基金 supported by grants from the One Hundred Talents Program of the Chinese Academy of Sciences(2012OHTP06) the National Basic Research Program of China(2012CB524900) the National Natural Science Foundation of China(91339110,31371153,31171133)
关键词 vascular remodeling mineralocorticoid receptor immune cell endothelial cell vascular smooth muscle cell FIBROBLAST 血管重塑 激素受体 皮质 血管平滑肌细胞 氧化应激反应 免疫细胞 球员
  • 相关文献

参考文献55

  • 1Gibbons GH, Dzau V.I. The emerging concept of vascular remodeling. N Engl J Med, 1994,330: 1431-1438.
  • 2Glagov S. Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med, 1987,316: 1371-1375.
  • 3Jones EA, Ie Noble F. Eichmann A. What determines blood vessel structure') Genetic prespecification vs. hemodynamics. Physiology, 2006,21: 388-395.
  • 4Potente M, Gerhardt H, Carmeliet P. Basic and therapeutic aspects of angiogenesis. Cell. 2011,146: 873-887.
  • 5Stenmark KR, Yeager ME, EI Kasmi KC Nozik-Grayck E, Gerasirnovskaya EV, Li M, Riddle SR, Frid MG. The adventitia: essential regulator of vascular wall structure and function. Annu Rev Physiol, 2013, 75: 23-47.
  • 6Stenmark KR, Frid MG, Yeager M, Li M, Riddle S, McKinsey T, EI Kasrni KC Targeting the adventitial microenvironment in pulmonary hypertension: a potential approach to therapy that considers epigenetic change. Pulmon circular, 2012, 2: 3-14.
  • 7Duan SZ, Usher MG, Mortensen RM. Peroxisome proliferatoractivated receptor-gamma-mediated effects in the vasculature. Circ Res, 2008,102: 2);3-294.
  • 8Swirski FK, Pittet MJ, Kircher MF, Aikawa E, Jaffer FA, Libby P. Weissleder R. Monocyte accumulation in mouse atherogenesis is progressive and proportional to extent of disease. Proc Natl Acad Sci USA, 2006, 103:10340-10345.
  • 9Robbins CS, Hilgendorf I, Weber GF. Theurl L Iwamoto v, Figueiredo JL, Gorbatov R. Sukhova GK, Gerhardt LM, Smyth D, Zavitz CC Shikatani EA, Parsons M, van Rooijen N, Lin HY, Husain M, Libby p, Nahrendorf M, Weissleder R, Swirski FK. Local proliferation dominates lesional macrophage accumulation in atherosclerosis. Nat Med, 20\3,19: 1166--1172.
  • 10Weber C. Noels H. Atherosclerosis: current pathogenesis and therapeutic options. Nat Med, 201 L 17: 1410-1422.

同被引文献3

引证文献3

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部